CureVac has announced an alliance with Bayer, as the German biotech firm starts a late-stage clinical trial of its COVID-19 vaccine candidate

Bayer shares plunged Thursday after it said it might have to write down the value of its agriculture assets by close to $12 billion.

Bayer acknowledges 'bumps' in $11 billion Roundup deal after judge raises doubts.